Materials scientist up to five retractions as publishers investigate dozens of his papers

A materials scientist in Australia, by way of Iran, has recently had five papers retracted for duplicating his prior work, and the reader who brought the issue to publishers’ attention says it could affect some 100 articles.

Ali Nazari, now of Swinburne University of Technology in Australia, was at Islamic Azad University in Iran when he published the five papers in Energy and Buildings, an Elsevier title, in 2010 and 2011. The retractions came sometime after January of this year, when an anonymous reader contacted Elsevier about dozens of Nazari’s papers.

A typical notice, for “Physical, mechanical and thermal properties of concrete in different curing media containing ZnO2 nanoparticles,” reads:

Continue reading Materials scientist up to five retractions as publishers investigate dozens of his papers

Journal expresses a great deal of concern over deceased author’s work

A gastroenterology journal has issued an extensive expression of concern about a 2013 paper by Yoshihiro Sato, a Japanese endocrinologist who has posthumously been climbing the Retraction Watch leaderboard. (He’s now ranked number three, ahead of Diederik Stapel.)

To call the statement an “expression of concern” is like calling Charles M. Schulz a talented cartoonist, or Escoffier a pretty good cook. Indeed, the journal expresses so much concern, about, well, so much, that we’re not sure what in the paper would be left unscathed. 

Sato, formerly of Hirosaki University, currently has 77 retractions for a range of misconduct-related issues including likely data fabrication and duplication.

Continue reading Journal expresses a great deal of concern over deceased author’s work

Weekend reads: Findings linked to $183 million deal questioned; how Jeffrey Epstein’s money blinded scientists; “a scientific Ponzi scheme”

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured the story of a bad trip for some drug researchers; a suspension for an earthquake researcher; and our ninth birthday. Here’s what was happening elsewhere:

Continue reading Weekend reads: Findings linked to $183 million deal questioned; how Jeffrey Epstein’s money blinded scientists; “a scientific Ponzi scheme”

Forensics Friday: What would you do if you were the reviewer?

Ever wanted to hone your skills as a scientific sleuth? Now’s your chance.

Thanks to the American Society for Biochemistry and Molecular Biology (ASBMB), which is committed to educating authors on best practices in publishingfigure preparation, and reproducibility, we’re presenting the eleventh in a series, Forensics Friday.

Take a look at the image below, and then take our poll. (We recommend using the Chrome browser.) After that, click on the link below to find out the right answer.

Continue reading Forensics Friday: What would you do if you were the reviewer?

Happy birthday, Retraction Watch: We’re turning nine

Nine years ago this coming Saturday, on August 3, 2010, we published a post, “Why write a blog about retractions?”

Why, indeed! 

What has become clear in the intervening nine years is what a rich vein retractions are as stories of what happens when something goes wrong in science. And as we have done every year at this time, we’ll review what happened in the last 12 months.

Continue reading Happy birthday, Retraction Watch: We’re turning nine

Drug researchers trip up, lifting meth paper to write one on LSD

via ImageCreator

Evidently meth is a gateway drug … for publishing misconduct. 

Researchers in China have lost a 2019 paper on how LSD can damage eyesight because they’d lifted much of the paper from an article that had appeared the year before in a different journal — about methamphetamine. 

The retracted article, “Long-term systemic treatment with lysergic acid diethylamide causes retinal damage in CD1 mice,” appeared in Human & Experimental Toxicology. According to the article

Continue reading Drug researchers trip up, lifting meth paper to write one on LSD

Authors object as “doubtful” data doom dermatology paper

King Fahad Medical City, Riyadh

A dermatology journal has retracted a 2017 article by a pair of researchers in Saudi Arabia after receiving a “serious complaint” about the integrity of the data. But the first author of the paper pushed back, saying the move was unjustified. 

The article, “Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa,” was written by Ibrahim Al-Homood and Mohammad Aljahlan, rheumatologists at King Fahad Medical City in Riyadh and appeared in the Journal of Dermatology & Dermatologic Surgery. It described (with rather grisly pictures) the case of a 25-year-old man with severe leg ulcers that resolved after the described combination therapy. 

But at the notice explains, the paper can’t be trusted:  

Continue reading Authors object as “doubtful” data doom dermatology paper

Kyoto University suspends first author of retracted Kumamoto quake paper

Damage from the 2016 Kumamoto earthquake

The first author of a now-retracted paper in Science about the effects of the deadly 2016 Kumamoto earthquake in Japan has been suspended from his university position for one year. 

Aiming Lin, of the Department of Geophysics at Kyoto University, was sanctioned by the institution for misconduct stemming from his misuse of data and plagiarism in the 2016 paper

Continue reading Kyoto University suspends first author of retracted Kumamoto quake paper

Weekend reads: A sleuth whose work has led to hundreds of retractions and corrections; an “unethical, risky and misleading” eye study; genetics’ high retraction rate

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance.

The week at Retraction Watch featured the story of how “pure, utter nonsense” appeared in a peer-reviewed journal; a cock and bull story; and an expression of concern for a paper about leeches. Here’s what was happening elsewhere:

Continue reading Weekend reads: A sleuth whose work has led to hundreds of retractions and corrections; an “unethical, risky and misleading” eye study; genetics’ high retraction rate

Forensics Friday: Would you flag this paper if it were under review?

Ever wanted to hone your skills as a scientific sleuth? Now’s your chance.

Thanks to the American Society for Biochemistry and Molecular Biology (ASBMB), which is committed to educating authors on best practices in publishingfigure preparation, and reproducibility, we’re presenting the tenth in a series, Forensics Friday.

Take a look at the image below, and then take our poll. After that, click on the link below to find out the right answer.

Continue reading Forensics Friday: Would you flag this paper if it were under review?